Alteration of fecal tryptophan metabolism correlates with shifted microbiota and may be involved in pathogenesis of colorectal cancer/Experiment 1

From BugSigDB


Reviewed Marked as Reviewed by Chloe on 2022/03/11

Curated date: 2022/01/26

Curator: Itslanapark

Revision editor(s): WikiWorks, Chloe, Itslanapark, Peace Sandy

Subjects

Location of subjects
China
Host species Species from which microbiome was sampled. Contact us to have more species added.
Homo sapiens
Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
Feces Cow dung,Cow pat,Droppings,Dung,Excrement,Excreta,Faeces,Fecal material,Fecal matter,Fewmet,Frass,Guano,Matières fécales@fr,Merde@fr,Ordure,Partie de la merde@fr,Piece of shit,Porción de mierda@es,Portion of dung,Portion of excrement,Portion of faeces,Portion of fecal material,Portion of fecal matter,Portion of feces,Portion of guano,Portion of scat,Portionem cacas,Scat,Spoor,Spraint,Stool,Teil der fäkalien@de,Feces,feces
Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
Colorectal cancer cancer of colorectum,cancer of large bowel,cancer of large intestine,cancer of the large bowel,colon cancer,colorectal cancer,colorectum cancer,CRC,large intestine cancer,malignant colorectal neoplasm,malignant colorectal tumor,malignant colorectum neoplasm,malignant large bowel neoplasm,malignant large bowel tumor,malignant large intestine neoplasm,malignant large intestine tumor,malignant neoplasm of colorectum,malignant neoplasm of large bowel,malignant neoplasm of large intestine,malignant neoplasm of the large bowel,malignant neoplasm of the large intestine,malignant tumor of large bowel,malignant tumor of large intestine,malignant tumor of the large bowel,malignant tumor of the large intestine,Colorectal cancer
Group 0 name Corresponds to the control (unexposed) group for case-control studies
Healthy Controls (HC)
Group 1 name Corresponds to the case (exposed) group for case-control studies
CRC
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
Patients with colorectal neoplastic lesions where tumors were removed and pathologically diagnosed with adenomatous polyp or colorectal adenocarcinoma; ages of participants ranged from 18-80.
Group 0 sample size Number of subjects in the control (unexposed) group
38
Group 1 sample size Number of subjects in the case (exposed) group
79
Antibiotics exclusion Number of days without antibiotics usage (if applicable) and other antibiotics-related criteria used to exclude participants (if any)
4 weeks

Lab analysis

Sequencing type
16S
16S variable region One or more hypervariable region(s) of the bacterial 16S gene
V3-V4
Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
Illumina

Statistical Analysis

Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).
relative abundances
Statistical test
LEfSe
Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
0.05
MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?
No
LDA Score above Threshold for the linear discriminant analysis (LDA) score for studies using the popular LEfSe tool
2.0
Matched on Factors on which subjects have been matched on in a case-control study
age, body mass index, sex

Alpha Diversity

Chao1 Abundance-based estimator of species richness
unchanged

Signature 1

Reviewed Marked as Reviewed by Chloe on 2022/03/11

Curated date: 2022/01/31

Curator: Itslanapark

Revision editor(s): Chloe, Itslanapark, Merit, Aiyshaaaa

Source: Figure 4C

Description: Linear discriminant analysis effect size analysis of fecal bacterial of colorectal cancer patients and HCs was used to represent which taxa were increased in CRC patients and which were enriched in healthy controls. Taxa enriched in HCs are indicated with a negative LDA score and taxa enriched in the CRC group are indicated with a positive LDA score.

Abundance in Group 1: increased abundance in CRC

NCBI Quality ControlLinks
Akkermansia
Anaerostipes
Bacilli
Bacteroidales
Bacteroidia
Bacteroidota
Corynebacteriaceae
Corynebacterium
Eggerthella
Enterobacterales
Enterobacteriaceae
Enterococcaceae
Enterococcus
Escherichia/Shigella sp.
Lactobacillaceae
Lactobacillales
Lactobacillus
Megasphaera
Parabacteroides
Parasutterella
Parvimonas
Peptostreptococcus
Porphyromonas
Selenomonas
Sutterella
Verrucomicrobiaceae
Verrucomicrobiia
Verrucomicrobiales
Verrucomicrobiota
Alphaproteobacteria
Enterobacter
unclassified Enterobacter
Lactobacillus sp.

Revision editor(s): Chloe, Itslanapark, Merit, Aiyshaaaa

Signature 2

Reviewed Marked as Reviewed by Chloe on 2022/03/11

Curated date: 2022/02/10

Curator: Itslanapark

Revision editor(s): Fatima, Chloe, Itslanapark, Merit

Source: Figure 4c

Description: Linear discriminant analysis effect size analysis of fecal bacterial of colorectal cancer patients and HCs was used to represent which taxa were increased in CRC patients and which were enriched in healthy controls. Taxa enriched in HCs are indicated with a negative LDA score and taxa enriched in the CRC group are indicated with a positive LDA score.

Abundance in Group 1: decreased abundance in CRC

NCBI Quality ControlLinks
Anaerofilum
Asaccharobacter
Bacillota
Blautia
Butyricicoccus
Clostridia
Clostridiales bacterium
Collinsella
Faecalibacterium
Fusicatenibacter
Fusobacteriaceae
Fusobacteriales
Fusobacteriia
Fusobacteriota
Fusobacterium
Gemmiger
Lachnospiraceae
Romboutsia
Roseburia
Tyzzerella
Fusobacterium sp.
Lachnospira
Lachnospira sp.

Revision editor(s): Fatima, Chloe, Itslanapark, Merit